CEL-SCI Gelecekteki Büyüme

Future kriter kontrolleri 0/6

CEL-SCI is forecast to grow earnings and revenue by 22.5% and 150% per annum respectively while EPS is expected to grow by 30.6% per annum.

Anahtar bilgiler

22.5%

Kazanç büyüme oranı

30.6%

EPS büyüme oranı

Biotechs kazanç büyümesi27.1%
Gelir büyüme oranı150.0%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme04 Sep 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Market Sentiment Around Loss-Making CEL-SCI Corporation (NYSEMKT:CVM)

Apr 29
Market Sentiment Around Loss-Making CEL-SCI Corporation (NYSEMKT:CVM)

We Think CEL-SCI (NYSEMKT:CVM) Can Afford To Drive Business Growth

Mar 01
We Think CEL-SCI (NYSEMKT:CVM) Can Afford To Drive Business Growth

What Does CEL-SCI's (NYSEMKT:CVM) CEO Pay Reveal?

Jan 25
What Does CEL-SCI's (NYSEMKT:CVM) CEO Pay Reveal?

Breakeven On The Horizon For CEL-SCI Corporation (NYSEMKT:CVM)

Dec 21
Breakeven On The Horizon For CEL-SCI Corporation (NYSEMKT:CVM)

Kazanç ve Gelir Büyüme Tahminleri

NYSEAM:CVM - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
9/30/202613-17N/AN/A2
9/30/2025N/A-31-32-293
9/30/2024N/A-39-39-363
6/30/2024N/A-29-19-19N/A
3/31/2024N/A-30-20-20N/A
12/31/2023N/A-31-23-23N/A
9/30/2023N/A-32-23-23N/A
6/30/2023N/A-34-23-23N/A
3/31/2023N/A-35-23-23N/A
12/31/2022N/A-37-19-18N/A
9/30/2022N/A-38-19-18N/A
6/30/2022N/A-37-19-18N/A
3/31/2022N/A-36-21-18N/A
12/31/2021N/A-37-26-20N/A
9/30/2021N/A-37-28-19N/A
6/30/20210-34-27-18N/A
3/31/20210-35-25-16N/A
12/31/20201-33-21-15N/A
9/30/20201-30-18-15N/A
6/30/20201-30-17-16N/A
3/31/20201-32-17-17N/A
12/31/20190-29-17-16N/A
9/30/20190-22-17-16N/A
6/30/20191-32-17-17N/A
3/31/20191-26-15-15N/A
12/31/20181-24-15-15N/A
9/30/20180-32-13-13N/A
6/30/20180-22-13-13N/A
3/31/20180-20N/A-13N/A
12/31/20170-24N/A-12N/A
9/30/2017N/A-14N/A-14N/A
6/30/20170-10N/A-17N/A
3/31/20170-10N/A-20N/A
12/31/20160-10N/A-21N/A
9/30/20160-12N/A-23N/A
6/30/20160-20N/A-22N/A
3/31/20160-21N/A-22N/A
12/31/20151-25N/A-24N/A
9/30/20151-35N/A-24N/A
6/30/20151-32N/A-24N/A
3/31/20150-30N/A-24N/A
12/31/20140-31N/A-22N/A
9/30/20140-28N/A-23N/A
6/30/20140-23N/A-21N/A
3/31/20140-25N/A-18N/A
12/31/20130-12N/A-16N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CVM is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: CVM is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: CVM is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: CVM is forecast to have no revenue next year.

Yüksek Büyüme Geliri: CVM is forecast to have no revenue next year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if CVM's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin